Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
Date:5/2/2013

costs and expenses for the 2013 period was primarily attributable to the timing of educational and marketing programs, combined with lower personnel costs for the company's hospital sales specialists. These reductions were partially offset by higher legal expenses incurred during the 2013 period related to the company's intellectual property litigation.

As of March 31, 2013, Cadence held cash, cash equivalents and short-term investments of $64.2 million, an increase of $2.1 million from the $62.1 million at December 31, 2012. Net accounts receivable at March 31, 2013, was $8.9 million.

GuidanceAs of May 2, 2013, Cadence is increasing its guidance to reflect the impact of the deferred revenue recognized in the first quarter of 2013. It now expects that net product revenue from sales of OFIRMEV for the twelve months ending December 31, 2013, will range from approximately $97.0 million to $103.0 million.

Conference Call and Webcast on May 2, 2013 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) Cadence management will host a conference call on May 2, 2013, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) and interested investors may participate in the conference call by dialing (877) 303-9145 (domestic) or (760) 536-5203 (international). To access the webcast, please visit the company's website at www.cadencepharm.com and go to the Investors page. A replay of the webcast will be available approximately two hours after the call and remain available on the company's website until the next quarterly financial results call. Cadence uses the Investors portion of its website as one means of disclosing material non-public information, and investors are encouraged to monitor Cadence's website in addition to following the company's press releases, SEC filings and public conference calls and webcasts.

About OFIRMEV® (Acetaminophen) InjectionOFIRMEV (acetaminophen) injection (1000 mg / 1
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
2. Cadence Pharmaceuticals To Present At The Deutsche Bank Securities, Inc. 37th Annual Health Care Conference In Boston On May 8, 2012
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
4. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
5. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
6. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
7. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
8. Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
9. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
10. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
11. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... -- The crowdfunding campaign for PosturePulse , a ... popular crowdfunding platform Kickstarter. Backers have already pledged over ... The $75,000 funding goal for the campaign was set ... Photo - http://photos.prnewswire.com/prnh/20140825/139254 ... back that silently vibrates if the wearer slouches for ...
(Date:8/26/2014)... Sauk Rapids, MN (PRWEB) August 26, 2014 ... Products and Assemblies for the Semiconductor, Medical Device, ... is a finalist for the Minnesota Business magazine’s fourth ... This follows the announcement in February that Talon ... (MSJP) Program to develop a robust new training program ...
(Date:8/25/2014)... Spirax Sarco , the leader ... to announce their latest training event: Basic Steam ... being held on December 15 - 19, 2014 at ... where participants will learn virtually all facets of steam ... is exclusively designed for Steam Plant Operations, Steam Plant ...
(Date:8/25/2014)... MONTREAL , Aug. 25, 2014 /CNW Telbec/ - NEOMED, ... bridge between academic research and the pharmaceutical industry, will ... Canada to help academic researchers ... was attained thanks to the success of NEOMED,s application ... "Very early in the creation process of NEOMED, about ...
Breaking Biology Technology:PosturePulse, A Biofeedback Posture-Improving Belt, Improves Posture While Sitting or Standing 2Talon Innovations Selected as Finalist for Minnesota Business Magazine Award 2Talon Innovations Selected as Finalist for Minnesota Business Magazine Award 3Spirax Sarco's Basic Steam Boiler Operator Training Course Is Coming in December to South Carolina 2NEOMED Receives $12 Million from Federal Government 2NEOMED Receives $12 Million from Federal Government 3
... MARINO, Calif., July 8 Epeius Biotechnologies,Corporation today ... by the U.S. Food and Drug Administration (FDA) ... including the rarity,seriousness, and current lack of effective ... and medicinal merit of Rexin-G, the,granting of Orphan ...
... MedPredict Market Research, a,global provider of pharmaceutical ... new report providing critical strategic insight,for pharma ... the market for Rheumatoid,Arthritis (RA) therapies., ... & Analysis: Rheumatoid,Arthritis Q2 2008, MedPredict,s global ...
... tests and evaluations result in 12-years of safe use. , ... St. ... and podcast released today, dietitian Mary Lee Chin describes the ... genetically modified foods. In the video, Chin discusses how consumers on a ...
Cached Biology Technology:Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma 2New MedPredict Report Highlights Trend Toward Early Diagnosis and Treatment of Rheumatoid Arthritis, Impact on Pharmaceutical Development 2Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video 2Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video 3Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video 4
(Date:8/26/2014)... mathematical sciences at New Jersey Institute of Technology (NJIT), ... clock that sets the pace for daily life. , ... other mammals with fundamental rhythms of life that include ... and with seasonal change. The brain,s circadian clock controls ... which, when disrupted by experiences such as jet lag ...
(Date:8/26/2014)... combining plasmonics and optical microresonators, researchers at the ... new optical amplifier (or laser) design, paving the ... made optical systems at the microscopic scale that ... J. Gary Eden, a professor of electrical and ... amplifiers are well-suited for routing optical power on ...
(Date:8/26/2014)... the University of Liverpool has recommended investing in dog owner ... and problems such as obesity in both people and their ... 1990, the researchers found that access to dog-friendly walking environments ... people to get out and take more exercise with their ... don,t take their dogs for a walk. In the UK, ...
Breaking Biology News(10 mins):Researching fundamental rhythms of life 2Researching fundamental rhythms of life 3Symphony of nanoplasmonic and optical resonators produces laser-like light emission 2Education and dog-friendly neighbourhoods could tackle obesity 2
... Research Center Oakland is the first children,s hospital in ... the way blood is analyzed at pediatric hospitals. This ... in some debit or credit cards at the supermarket ... The procedure starts with a respiratory therapist who ...
... A recent study conducted in the Midwestern United States ... cultivated and uncultivated soils, vastly advancing the knowledge of ... soil attribute that is related to the physical-chemical state ... processes that determine soil quality. During the wet season ...
... years after the AIDS epidemic spawned a worldwide search ... (HIV), progress in the field seems to have effectively ... a team of researchers from the California Institute of ... fact that our body,s natural HIV antibodies simply don,t ...
Cached Biology News:Children's Hospital Oakland is first pediatric hospital to use 'laboratory-on-a-card' technology 2Impact of floods on soils 2Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection 2Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection 3